230 related articles for article (PubMed ID: 28764837)
21. Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors.
Timmer-Bonte JN; Tjan-Heijnen VC
Anticancer Drugs; 2006 Sep; 17(8):881-9. PubMed ID: 16940798
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of the oral neurokinin-1 receptor antagonist aprepitant for nausea and vomiting induced by cisplatin and carboplatin in Japanese patients with gynecological cancer.
Ikeda M; Shida M; Hirasawa T; Muramatsu T; Mikami M
J Obstet Gynaecol Res; 2017 Oct; 43(10):1613-1620. PubMed ID: 28691209
[TBL] [Abstract][Full Text] [Related]
23. [Antineoplastic drug-induced neutropenia: use of granulocyte colony stimulating factors].
Carrato A; Guillén-Ponce C; Grande-Pulido E
Farm Hosp; 2010 Mar; 34 Suppl 1():8-11. PubMed ID: 20920851
[TBL] [Abstract][Full Text] [Related]
24. [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].
Shi YK; Liu P; Yang S; Han XH; He XH; Ai B; Qin Y; Li B; Huang DZ; Zhang CG; Sun Y
Ai Zheng; 2006 Apr; 25(4):495-500. PubMed ID: 16613688
[TBL] [Abstract][Full Text] [Related]
25. Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors.
Danova M; Barni S; Del Mastro L; Danesi R; Pappagallo GL
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1303-13. PubMed ID: 21916584
[TBL] [Abstract][Full Text] [Related]
26. New treatments on the horizon for chemoradiotherapy-induced nausea and vomiting.
Ruhlmann CH; Herrstedt J
Expert Opin Pharmacother; 2016 Aug; 17(12):1623-9. PubMed ID: 27322893
[TBL] [Abstract][Full Text] [Related]
27. 5-HT(3)-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile.
Goodin S; Cunningham R
Oncologist; 2002; 7(5):424-36. PubMed ID: 12401905
[TBL] [Abstract][Full Text] [Related]
28. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.
Aapro MS; Bohlius J; Cameron DA; Dal Lago L; Donnelly JP; Kearney N; Lyman GH; Pettengell R; Tjan-Heijnen VC; Walewski J; Weber DC; Zielinski C;
Eur J Cancer; 2011 Jan; 47(1):8-32. PubMed ID: 21095116
[TBL] [Abstract][Full Text] [Related]
29. [Tips on the use of granulocyte colony-stimulating factors in cancer patients predisposed to chemotherapy - induced febrile neutropenia].
Murakawa Y
Gan To Kagaku Ryoho; 2013 Jun; 40(6):693-6. PubMed ID: 23863645
[TBL] [Abstract][Full Text] [Related]
30. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
Liang DC
Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
[TBL] [Abstract][Full Text] [Related]
31. Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.
Sharma R; Tobin P; Clarke SJ
Lancet Oncol; 2005 Feb; 6(2):93-102. PubMed ID: 15683818
[TBL] [Abstract][Full Text] [Related]
32. 5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study.
Matsui R; Suzuki K; Takiguchi T; Nishio M; Koike T; Hayashi T; Seto T; Kogure Y; Nogami N; Fujiwara K; Kaneda H; Harada T; Shimizu S; Kimura M; Kenmotsu H; Shimokawa M; Goto K
BMC Pharmacol Toxicol; 2020 Oct; 21(1):72. PubMed ID: 33023657
[TBL] [Abstract][Full Text] [Related]
33. Neurokinin-1-receptor antagonists: a new approach in antiemetic therapy.
Jordan K
Onkologie; 2006 Feb; 29(1-2):39-43. PubMed ID: 16514255
[TBL] [Abstract][Full Text] [Related]
34. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
35. [Prevention and treatment of chemotherapy-induced digestive toxicities].
Boige V; Ducreux M
Bull Cancer; 2001 Feb; 88(2):163-73. PubMed ID: 11257591
[TBL] [Abstract][Full Text] [Related]
36. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.
Aapro MS; Cameron DA; Pettengell R; Bohlius J; Crawford J; Ellis M; Kearney N; Lyman GH; Tjan-Heijnen VC; Walewski J; Weber DC; Zielinski C;
Eur J Cancer; 2006 Oct; 42(15):2433-53. PubMed ID: 16750358
[TBL] [Abstract][Full Text] [Related]
37. A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin-Based Chemotherapy-Induced Nausea and Vomiting in Japan.
Iihara H; Shimokawa M; Hayashi T; Kawazoe H; Saeki T; Aiba K; Tamura K
Oncologist; 2020 Feb; 25(2):e373-e380. PubMed ID: 32043774
[TBL] [Abstract][Full Text] [Related]
38. Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy.
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):619-25. PubMed ID: 10348292
[TBL] [Abstract][Full Text] [Related]
39. Optimizing antiemetic therapy in multiple-day and multiple cycles of chemotherapy.
Ellebaek E; Herrstedt J
Curr Opin Support Palliat Care; 2008 Mar; 2(1):28-34. PubMed ID: 18685391
[TBL] [Abstract][Full Text] [Related]
40. Management of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM).
Tralongo AC; Antonuzzo A; Pronzato P; Sbrana A; Turrini M; Zoratto F; Danova M
Tumori; 2020 Aug; 106(4):273-280. PubMed ID: 32538316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]